Skip to main content
رجوع
RPRX logo

Royalty Pharma plc

جودة البيانات: 100%
RPRX
NASDAQ Healthcare Biotechnology
KWD 47.03
▲ KWD 1.46 (3.20%)
القيمة السوقية: 20.15B
نطاق اليوم
KWD 45.79 KWD 47.08
نطاق 52 أسبوعًا
KWD 29.66 KWD 47.86
حجم التداول
3,268,143
متوسط 50 يوم / 200 يوم
KWD 43.70 / KWD 38.65
الإغلاق السابق
KWD 45.57

Quick Summary

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Healthcare (627 نظير)

المقياس السهم وسيط القطاع
P/E 26.1 0.3
P/B 3.1 3.0
ROE % 11.5 3.7
Net Margin % 32.4 3.8
Rev Growth 5Y % 1.0 10.0
D/E 1.4 0.2

السعر المستهدف للمحللين

Hold
KWD 49.40 +5.0%
Low: KWD 42.00 High: KWD 61.00
مكرر الربحية المستقبلي
9.69
ربحية السهم المستقبلية
KWD 4.86
نمو ربحية السهم (تقدير)
+0.0%
الإيرادات المقدّرة
3.25B

تقديرات الأرباح

الفترة تقدير ربحية السهم تقدير الإيرادات المحللون
FY2030 KWD 7.71
KWD 7.54 – KWD 7.88
4.99B 1
FY2029 KWD 7.04
KWD 6.89 – KWD 7.19
4.59B 1
FY2028 KWD 6.08
KWD 5.95 – KWD 6.22
3.97B 1

Earnings Surprises

Last 8 quarters
Quarter Est. EPS Actual EPS Surprise
2026-02-11 KWD 1.29 KWD 1.46 +13.2%
2025-11-05 KWD 0.99 KWD 1.17 +17.7%
2025-08-06 KWD 1.03 KWD 1.14 +10.7%
2025-05-08 KWD 0.95 KWD 1.06 +11.2%
2025-02-11 KWD 0.99 KWD 1.15 +16.2%
2024-11-06 KWD 0.93 KWD 1.04 +12.1%
2024-08-08 KWD 0.97 KWD 0.96 -0.5%
2024-05-09 KWD 0.99 KWD 0.98 -0.7%

Dividend History

6 yr streak

Yield

0.02%

Payout Ratio

0.49%

Growth (3Y)

5.01%

Growth (5Y)

24.01%

Ex-Date Payment Date Amount Yield
Feb 20, 2026 Mar 10, 2026 KWD 0.24 1.98%
Nov 14, 2025 Dec 10, 2025 KWD 0.22 2.25%
Aug 15, 2025 Sep 10, 2025 KWD 0.22 2.39%
May 16, 2025 Jun 10, 2025 KWD 0.22 2.53%
Feb 21, 2025 Mar 10, 2025 KWD 0.22 2.54%
Nov 15, 2024 Dec 10, 2024 KWD 0.21 3.27%
Aug 16, 2024 Sep 13, 2024 KWD 0.21 3.05%
May 16, 2024 Jun 14, 2024 KWD 0.21 2.94%
Feb 15, 2024 Mar 15, 2024 KWD 0.21 2.70%
Nov 16, 2023 Dec 15, 2023 KWD 0.20 3.02%
Aug 17, 2023 Sep 15, 2023 KWD 0.20 2.70%
May 18, 2023 Jun 15, 2023 KWD 0.20 2.32%
Feb 15, 2023 Mar 15, 2023 KWD 0.20 2.04%
Nov 17, 2022 Dec 15, 2022 KWD 0.19 1.80%
Aug 18, 2022 Sep 15, 2022 KWD 0.19 1.68%
May 19, 2022 Jun 15, 2022 KWD 0.19 1.81%
Feb 17, 2022 Mar 15, 2022 KWD 0.19 1.76%
Nov 18, 2021 Dec 15, 2021 KWD 0.17 1.62%
Aug 19, 2021 Sep 15, 2021 KWD 0.17 1.70%
May 19, 2021 Jun 15, 2021 KWD 0.17 1.60%

النقاط الرئيسية

Revenue grew 0.96% annually over 5 years — modest growth
Earnings declined -10.25% over the past year
ROE of 11.49% — decent returns on equity
Net margin of 32.42% shows strong profitability
Generating 2.49B in free cash flow
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 4.10%

النمو

Revenue Growth (5Y)
0.96%
Revenue (1Y)5.06%
Earnings (1Y)-10.25%
FCF Growth (3Y)-8.71%

الجودة

Return on Equity
11.49%
ROIC7.58%
Net Margin32.42%
Op. Margin65.58%

الأمان

Debt / Equity
1.38
Current Ratio0.97
Interest Coverage5.07

التقييم

P/E Ratio
26.14
Forward P/E9.39
P/B Ratio3.11
EV/EBITDA18.26
Dividend Yield0.02%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 5.06% Revenue Growth (3Y) 0.50%
Earnings Growth (1Y) -10.25% Earnings Growth (3Y) -17.58%
Revenue Growth (5Y) 0.96% Earnings Growth (5Y) 5.61%
Profitability
Revenue (TTM) 2.38B Net Income (TTM) 770.95M
ROE 11.49% ROA 3.93%
Gross Margin 100.00% Operating Margin 65.58%
Net Margin 32.42% Free Cash Flow (TTM) 2.49B
ROIC 7.58% FCF Growth (3Y) -8.71%
Safety
Debt / Equity 1.38 Current Ratio 0.97
Interest Coverage 5.07
Dividends
Dividend Yield 0.02% Payout Ratio 0.49%
Dividend Growth (3Y) 5.01% Dividend Growth (5Y) 24.01%
Consecutive Div Years 6 yrs
Valuation
P/E Ratio 26.14 Forward P/E 9.39
P/B Ratio 3.11 P/S Ratio 8.47
PEG Ratio 1.04 Forward PEG N/A
EV/EBITDA 18.26 Fwd EV/EBITDA 14.63
Forward P/S 6.19 Fwd Earnings Yield 10.65%
FCF Yield 12.36%
Market Cap 20.15B Enterprise Value 28.48B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 2.38B 2.26B 2.35B 2.24B 2.29B
Net Income 770.95M 858.98M 1.13B 42.83M 619.73M
EPS (Diluted) 1.80 1.45 2.53 0.10 1.49
Gross Profit 2.38B 2.26B 2.35B 2.24B 2.29B
Operating Income 1.56B 1.29B 1.49B 307.07M 1.43B

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 19.62B 18.22B 16.38B 16.81B 17.52B
Total Liabilities 9.91B 7.88B 6.30B 7.29B 7.27B
Shareholders' Equity 6.48B 6.95B 6.53B 5.63B 5.78B
Total Debt 8.95B 7.61B 6.14B 7.12B 7.10B
Cash & Equivalents 618.70M 929.03M 477.01M 1.71B 1.54B
Current Assets 619.00M 1.80B 1.27B 2.55B 2.88B
Current Liabilities 636.21M 1.25B 161.38M 1.17B 171.25M

درجات الاستراتيجيات

This stock passed the criteria for 1 strategy

Score = fit strength (0–100)
Rank = position among all matches
#354 of 1052
53

النشاط الأخير

دخل Cash Flow Compounder
Mar 24, 2026